Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-04-27
DOI
10.1038/s41467-022-29915-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Modulation of the monomer-dimer equilibrium and catalytic activity of SARS-CoV-2 main protease by a transition-state analog inhibitor
- (2022) Nashaat T. Nashed et al. Communications Biology
- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
- (2021) Pengfei Wang et al. NATURE
- SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model
- (2021) Jingxin Qiao et al. SCIENCE
- A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication
- (2021) Shin-ichiro Hattori et al. Nature Communications
- Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations
- (2021) Chun-Hui Zhang et al. ACS Central Science
- Direct Observation of Protonation State Modulation in SARS-CoV-2 Main Protease upon Inhibitor Binding with Neutron Crystallography
- (2021) Daniel W. Kneller et al. JOURNAL OF MEDICINAL CHEMISTRY
- Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors
- (2021) Naoya Kitamura et al. JOURNAL OF MEDICINAL CHEMISTRY
- Post-acute COVID-19 syndrome
- (2021) Ani Nalbandian et al. NATURE MEDICINE
- Impact of the Delta variant on vaccine efficacy and response strategies
- (2021) Lianlian Bian et al. Expert Review of Vaccines
- Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CLpro)
- (2021) Sang Hoon Han et al. JOURNAL OF MEDICINAL CHEMISTRY
- Indole Chloropyridinyl Ester-Derived SARS-CoV-2 3CLpro Inhibitors: Enzyme Inhibition, Antiviral Efficacy, Structure–Activity Relationship, and X-ray Structural Studies
- (2021) Arun K. Ghosh et al. JOURNAL OF MEDICINAL CHEMISTRY
- 3CL Protease Inhibitors with an Electrophilic Arylketone Moiety as Anti-SARS-CoV-2 Agents
- (2021) Sho Konno et al. JOURNAL OF MEDICINAL CHEMISTRY
- Peptidomimetic α-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and in Vitro Biological Stability
- (2021) Bing Bai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease
- (2021) Maya G. Deshmukh et al. STRUCTURE
- Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease
- (2021) Elizabeth A. MacDonald et al. ACS Infectious Diseases
- High-Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Noncovalent Inhibitor
- (2021) Austin Clyde et al. Journal of Chemical Information and Modeling
- Biotin’s Lessons in Drug Design
- (2021) Darryl B. McConnell JOURNAL OF MEDICINAL CHEMISTRY
- Structural, Electronic, and Electrostatic Determinants for Inhibitor Binding to Subsites S1 and S2 in SARS-CoV-2 Main Protease
- (2021) Daniel W. Kneller et al. JOURNAL OF MEDICINAL CHEMISTRY
- Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2
- (2021) Matan Levine-Tiefenbrun et al. NATURE MEDICINE
- An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
- (2021) Dafydd R. Owen et al. SCIENCE
- Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
- (2021) Britton Boras et al. Nature Communications
- Michaelis-like complex of SARS-CoV-2 main protease visualized by room-temperature X-ray crystallography
- (2021) Daniel W. Kneller et al. IUCrJ
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV
- (2020) Jiabao Xu et al. Viruses-Basel
- Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics
- (2020) Arun K. Ghosh et al. ChemMedChem
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
- (2020) Wenhao Dai et al. SCIENCE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Comprehensive Insights into the Catalytic Mechanism of Middle East Respiratory Syndrome 3C-Like Protease and Severe Acute Respiratory Syndrome 3C-Like Protease
- (2020) Hao Wang et al. ACS Catalysis
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
- (2020) Chunlong Ma et al. CELL RESEARCH
- Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
- (2020) Laura Riva et al. NATURE
- 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice
- (2020) Athri D. Rathnayake et al. Science Translational Medicine
- Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography
- (2020) Daniel W. Kneller et al. Nature Communications
- The SARS-CoV-2 main protease as drug target
- (2020) Sven Ullrich et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Unusual zwitterionic catalytic site of SARS-CoV-2 main protease revealed by neutron crystallography
- (2020) Daniel W. Kneller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19
- (2020) Robert L. Hoffman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Malleability of the SARS-CoV-2 3CL Mpro active site cavity facilitates binding of clinical antivirals
- (2020) Daniel W. Kneller et al. STRUCTURE
- Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease
- (2020) Lifeng Fu et al. Nature Communications
- Room-temperature neutron and X-ray data collection of 3CL Mpro from SARS-CoV-2
- (2020) Daniel W. Kneller et al. Acta Crystallographica Section F-Structural Biology Communications
- A Quick Route to Multiple Highly Potent SARS‐CoV‐2 Main Protease Inhibitors**
- (2020) Kai S. Yang et al. ChemMedChem
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- CNS implications of COVID-19: a comprehensive review
- (2020) Priyanka Nagu et al. REVIEWS IN THE NEUROSCIENCES
- Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix
- (2019) Dorothee Liebschner et al. Acta Crystallographica Section D-Structural Biology
- Current Developments in Coot for Macromolecular Model Building of Electron Cryo‐microscopy and Crystallographic Data
- (2019) Ana Casañal et al. PROTEIN SCIENCE
- Noncovalent Interactions of Fluorine with Amide and CH2 Groups in N-Phenyl γ-Lactams: Covalently Identical Fluorine Atoms in Nonequivalent Chemical Environments
- (2018) Ning Xi et al. JOURNAL OF ORGANIC CHEMISTRY
- A suite-level review of the neutron single-crystal diffraction instruments at Oak Ridge National Laboratory
- (2018) L. Coates et al. REVIEW OF SCIENTIFIC INSTRUMENTS
- The Neutron Macromolecular Crystallography Instruments at Oak Ridge National Laboratory: Advances, Challenges, and Opportunities
- (2018) Flora Meilleur et al. Crystals
- Direct Spectroscopic Evidence for an n→π* Interaction
- (2016) Santosh K. Singh et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Pharmacokinetics of New HCV NS3 Protease Inhibitor Narlaprevir Following Single Dose Use with or without Ritonavir in patients with liver cirrhosis.
- (2016) V Isakov et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS
- (2016) Arun K. Ghosh et al. JOURNAL OF MEDICINAL CHEMISTRY
- How good are my data and what is the resolution?
- (2013) Philip R. Evans et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding
- (2013) Mark Turlington et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studies
- (2013) Pillaiyar Thanigaimalai et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety
- (2012) Sho Konno et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design, synthesis and crystallographic analysis of nitrile-based broad-spectrum peptidomimetic inhibitors for coronavirus 3C-like proteases
- (2012) Chi-Pang Chuck et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery, Synthesis, And Structure-Based Optimization of a Series of N-(tert-Butyl)-2-(N-arylamido)-2-(pyridin-3-yl) Acetamides (ML188) as Potent Noncovalent Small Molecule Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease
- (2012) Jon Jacobs et al. JOURNAL OF MEDICINAL CHEMISTRY
- Overview of theCCP4 suite and current developments
- (2011) Martyn D. Winn et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease
- (2011) Lili Zhu et al. ANTIVIRAL RESEARCH
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease Inhibitor
- (2010) Ashok Arasappan et al. ACS Medicinal Chemistry Letters
- Generalized X-ray and neutron crystallographic analysis: more accurate and complete structures for biological macromolecules
- (2009) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- electronic Ligand Builder and Optimization Workbench(eLBOW): a tool for ligand coordinate and restraint generation
- (2009) Nigel W. Moriarty et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- MolProbity: all-atom structure validation for macromolecular crystallography
- (2009) Vincent B. Chen et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now